Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis.
Boziki M, Pechlivanis A, Virgiliou C, Bakirtzis C, Sintila SA, Karafoulidou E, Kesidou E, Theotokis P, Nikolaidis I, Theodoridis G, Gika H, Grigoriadis N. Boziki M, et al. Among authors: nikolaidis i. Int J Mol Sci. 2022 Nov 23;23(23):14578. doi: 10.3390/ijms232314578. Int J Mol Sci. 2022. PMID: 36498904 Free PMC article.
Long-term effects of prolonged-release fampridine in cognitive function, fatigue, mood and quality of life of MS patients: The IGNITE study.
Bakirtzis C, Konstantinopoulou E, Langdon DW, Grigoriadou E, Minti F, Nikolaidis I, Boziki MK, Tatsi T, Ioannidis P, Karapanayiotides T, Afrantou T, Hadjigeorgiou G, Grigoriadis N. Bakirtzis C, et al. Among authors: nikolaidis i. J Neurol Sci. 2018 Dec 15;395:106-112. doi: 10.1016/j.jns.2018.10.004. Epub 2018 Oct 4. J Neurol Sci. 2018. PMID: 30308444
Induction of apoptosis in CD4(+) T-cells is linked with optimal treatment response in patients with relapsing-remitting multiple sclerosis treated with Glatiramer acetate.
Boziki M, Lagoudaki R, Melo P, Kanidou F, Bakirtzis C, Nikolaidis I, Grigoriadou E, Afrantou T, Tatsi T, Matsi S, Grigoriadis N. Boziki M, et al. Among authors: nikolaidis i. J Neurol Sci. 2019 Jun 15;401:43-50. doi: 10.1016/j.jns.2019.03.030. Epub 2019 Mar 29. J Neurol Sci. 2019. PMID: 31009931
Deciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays.
Tzartos JS, Karagiorgou K, Tzanetakos D, Breza M, Evangelopoulos ME, Pelidou SH, Bakirtzis C, Nikolaidis I, Koutsis G, Notas K, Chroni E, Markakis I, Grigoriadis NC, Anagnostouli M, Orologas A, Parisis D, Karapanayiotides T, Papadimitriou D, Kostadima V, Elloul J, Xidakis I, Maris T, Zisimopoulou P, Tzartos S, Kilidireas C. Tzartos JS, et al. Among authors: nikolaidis i. J Neurol Sci. 2020 Mar 15;410:116673. doi: 10.1016/j.jns.2020.116673. Epub 2020 Jan 7. J Neurol Sci. 2020. PMID: 31954354
Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk.
Boziki MK, Karapanayotides T, Papadopoulos G, Lagoudaki R, Melo P, Bakirtzis C, Nikolaidis I, Gounari E, Tsavdaridou V, Skoura L, Afrantou T, Tatsi T, Grigoriadou E, Polyzoidou E, Mandoras N, Giantzi V, Kalogera-Fountzila A, Ioannidis P, Parissis D, Pelidou SH, Zoidou S, Grigoriadis N. Boziki MK, et al. Among authors: nikolaidis i. Neurol Res. 2020 Mar;42(3):209-221. doi: 10.1080/01616412.2020.1722913. Epub 2020 Feb 12. Neurol Res. 2020. PMID: 32048570
Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options.
Andravizou A, Dardiotis E, Artemiadis A, Sokratous M, Siokas V, Tsouris Z, Aloizou AM, Nikolaidis I, Bakirtzis C, Tsivgoulis G, Deretzi G, Grigoriadis N, Bogdanos DP, Hadjigeorgiou GM. Andravizou A, et al. Among authors: nikolaidis i. Auto Immun Highlights. 2019 Aug 10;10(1):7. doi: 10.1186/s13317-019-0117-5. eCollection 2019 Dec. Auto Immun Highlights. 2019. PMID: 32257063 Free PMC article. Review.
57 results